WRBY
Warby Parker Inc.NYSEResearch view
Healthcare · Ophthalmic Goods · Mid-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$2.9B
Enterprise Value$2.7B
Income$1.6M
Sales$871.9M
Book/sh$3.25
Cash/sh$2.53
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio2.05
Current Ratio2.35
Debt/Eq—
EPS (ttm)$0.01
EPS this Y105.9%
EPS past 3/5Y—
Sales past 3/5Y13.4%
EPS Y/Y TTM105.9%
Sales Y/Y TTM13.0%
Shs Outstand113.18M
ROA0.2%
ROE0.4%
ROIC-3.5%
Gross Margin54.0%
Oper. Margin-0.6%
Profit Margin0.2%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$540.8M
2021
$598.1M
2022
$669.8M
2023
$771.3M
2024
$871.9M
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $540.8M | $598.1M | $669.8M | $771.3M | $871.9M |
| Gross Profit | $317.7M | $341.1M | $365.2M | $426.8M | $470.6M |
| Operating Income | $-143.7M | $-111.2M | $-72.0M | $-30.1M | $-5.3M |
| Net Income | $-144.3M | $-110.4M | $-63.2M | $-20.4M | $1.6M |
| Diluted EPS | $-2.21 | $-0.96 | $-0.54 | $-0.17 | $0.01 |
| Operating Cash Flow | $-32.0M | $10.4M | $61.0M | $98.7M | $110.8M |
| Free Cash Flow | $-80.5M | $-49.8M | $7.3M | $34.7M | $43.7M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $67.0M against $110.8M operating cash
COMMUNITY · $WRBY0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Ophthalmic Goods
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.